AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014
Oct 1, 2014
30339_dirs_2014-10-01_14acac06-f64b-4db5-9468-375b27f7e104.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-09-29
Reporting Person: Flynn Karen (President, America's Region)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-29 | Stock Option (Right to Buy) | $44.9500 | A | 15528.0000 | Acquired | 2024-09-29 | Common Stock (15528.0000) | Direct |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12